Abstract:Diabetes mellitus, which comprises a group of metabolic disorders affecting carbohydrate metabolism, is characterized by improper glucose utilization and excessive production, leading to hyperglycemia. The global prevalence of diabetes is rising, with projections indicating it will affect 783.2 million people by 2045. Insulin treatment is crucial, especially for type 1 diabetes, due to the lack of β-cell function. Intensive insulin therapy, involving multiple daily injections or continuous subcutaneous insulin infusion, has proven effective in reducing microvascular complications but poses a higher risk of severe hypoglycemia. Recent advancements in insulin formulations and delivery methods, such as ultra-rapid-acting analogs and inhaled insulin, offer potential benefits in terms of reducing hypoglycemia and improving glycemic control. However, the traditional subcutaneous injection method has drawbacks, including patient compliance issues and associated complications. Nanomedicine presents innovative solutions to these challenges, offering promising avenues for overcoming current drug limitations, enhancing cellular uptake, and improving pharmacokinetics and pharmacodynamics. Various nanocarriers, including liposomes, chitosan, and PLGA, provide protection against enzymatic degradation, improving drug stability and controlled release. These nanocarriers offer unique advantages, ranging from enhanced bioavailability and sustained release to specific targeting capabilities. While oral insulin delivery is being explored for better patient adherence and cost-effectiveness, other nanomedicine-based methods also show promise in improving delivery efficiency and patient outcomes. Safety concerns, including potential toxicity and immunogenicity issues, must be addressed, with the FDA providing guidance for the safe development of nanotechnology-based products. Future directions in nanomedicine will focus on creating next-generation nanocarriers with precise targeting, real-time monitoring, and stimuli-responsive features to optimize diabetes treatment outcomes and patient safety. This review delves into the current state of nanomedicine for insulin delivery, examining various types of nanocarriers and their mechanisms of action, and discussing the challenges and future directions in developing safe and effective nanomedicine-based therapies for diabetes management.

Nanoparticle Delivery Systems in the Treatment of Diabetes Complications

Advances in Nanomedicine for Precision Insulin Delivery

Nanomedicine in the Treatment of Diabetes

Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy

Nanotechnology-Based Approaches for the Management of Diabetes Mellitus: An Innovative Solution to Long-Lasting Challenges in Antidiabetic Drug Delivery

Advancements in Oral Insulin: A Century of Research and the Emergence of Targeted Nanoparticle Strategies

Advances in oral peptide drug nanoparticles for diabetes mellitus treatment

Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds

Nanomedicine-based potential phyto-drug delivery systems for diabetes

Engineered nanoparticles in non-invasive insulin delivery for precision therapeutics of diabetes

Nanocarriers and Diabetes: New Vistas and the Way Ahead

Versatile Oral Insulin Delivery Nanosystems: From Materials to Nanostructures

Recent advances of nanomedicine-based strategies in diabetes and complications management: Diagnostics, monitoring, and therapeutics

An apprise on novel drug delivery systems for management of diabetes mellitus

Recent Progress of Chitosan and Chitosan Derivatives-Based Nanoparticles: Pharmaceutical Perspectives of Oral Insulin Delivery

Nanomaterial-Enhanced Microneedles: Emerging Therapies for Diabetes and Obesity

Drug Delivery System in the Treatment of Diabetes Mellitus

Importance of Integrating Nanotechnology with Pharmacology and Physiology for Innovative Drug Delivery and Therapy – an Illustration with Firsthand Examples

An Overview of Herbal-Based Antidiabetic Drug Delivery Systems: Focus on Lipid- and Inorganic-Based Nanoformulations

Nanomaterials Drug Delivery System in Herbal Formulation For Antidiabetic Activity: A Review

Drug Transport Mechanism of Oral Antidiabetic Nanomedicines